Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jason Farrar

Concepts (258)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
15
2024
180
3.260
Why?
Anemia, Diamond-Blackfan
13
2024
13
2.820
Why?
Mutation
15
2023
1288
1.770
Why?
Ribosomal Proteins
9
2021
25
1.540
Why?
Critical Illness
2
2024
301
0.970
Why?
Midazolam
1
2024
37
0.940
Why?
Hypnotics and Sedatives
1
2024
74
0.900
Why?
Gene Expression Profiling
7
2023
1029
0.850
Why?
Rhabdomyosarcoma, Alveolar
1
2021
8
0.770
Why?
Li-Fraumeni Syndrome
1
2021
12
0.770
Why?
Tumor Suppressor Protein p53
1
2021
214
0.680
Why?
RNA Processing, Post-Transcriptional
3
2014
24
0.560
Why?
GATA1 Transcription Factor
2
2017
7
0.500
Why?
Oncogene Proteins, Fusion
4
2024
59
0.490
Why?
RNA, Ribosomal
1
2014
20
0.470
Why?
RNA Precursors
1
2014
9
0.470
Why?
Codon, Initiator
1
2014
9
0.460
Why?
Humans
46
2024
50201
0.460
Why?
Meningitis, Cryptococcal
2
2010
10
0.460
Why?
Child, Preschool
16
2021
3896
0.450
Why?
Point Mutation
1
2014
65
0.450
Why?
Breast Neoplasms
1
2021
1187
0.400
Why?
Prognosis
6
2024
1963
0.390
Why?
Cryptococcus neoformans
2
2010
27
0.380
Why?
Infant
12
2021
3584
0.380
Why?
Amplified Fragment Length Polymorphism Analysis
1
2010
3
0.370
Why?
Mycological Typing Techniques
1
2010
2
0.370
Why?
Child
20
2024
6862
0.360
Why?
DNA, Fungal
1
2010
43
0.360
Why?
Gene Deletion
1
2011
267
0.360
Why?
Female
20
2024
26829
0.350
Why?
Male
19
2024
25572
0.290
Why?
DNA Methylation
6
2023
546
0.280
Why?
Intensive Care Units
2
2024
224
0.260
Why?
Polymorphism, Single Nucleotide
4
2013
484
0.250
Why?
Oligonucleotide Array Sequence Analysis
3
2011
409
0.240
Why?
Nutritional Support
1
2024
35
0.240
Why?
Adolescent
11
2022
6459
0.230
Why?
Prospective Studies
4
2024
2396
0.230
Why?
Hemophilia A
1
2024
25
0.220
Why?
Young Adult
10
2024
4052
0.220
Why?
Neurosurgical Procedures
1
2024
122
0.220
Why?
Gene Rearrangement
1
2024
73
0.220
Why?
Cell Cycle Proteins
2
2021
166
0.210
Why?
Chromatography, High Pressure Liquid
1
2024
326
0.210
Why?
Consensus
1
2024
158
0.210
Why?
Osteosarcoma
1
2023
45
0.210
Why?
Adult
10
2024
13486
0.210
Why?
Dengue
2
2013
4
0.200
Why?
Azacitidine
2
2023
34
0.200
Why?
Chromosome Aberrations
3
2017
295
0.200
Why?
Blood Glucose
1
2024
434
0.200
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
16
0.200
Why?
Middle Aged
8
2024
12356
0.190
Why?
Bone Neoplasms
1
2023
178
0.190
Why?
Aged
6
2024
9505
0.190
Why?
Co-Repressor Proteins
1
2021
18
0.190
Why?
Neoplasms, Second Primary
1
2022
74
0.190
Why?
Diabetes Mellitus
1
2024
281
0.190
Why?
Gene Regulatory Networks
1
2021
107
0.180
Why?
Chromosomal Proteins, Non-Histone
1
2021
35
0.180
Why?
B-Lymphocytes
1
2021
175
0.180
Why?
Chromatin
1
2021
138
0.170
Why?
Leucine
1
2020
118
0.170
Why?
Blood Transfusion
1
2020
127
0.170
Why?
MicroRNAs
2
2021
349
0.170
Why?
Vietnam
4
2013
24
0.160
Why?
Recurrence
2
2022
660
0.160
Why?
Ribosomes
2
2009
36
0.160
Why?
Research Report
1
2018
16
0.150
Why?
DNA-Binding Proteins
1
2021
424
0.150
Why?
Induction Chemotherapy
1
2017
60
0.140
Why?
Ribosome Subunits, Large, Eukaryotic
2
2014
2
0.140
Why?
Agammaglobulinemia
1
1996
9
0.140
Why?
X Chromosome
1
1996
12
0.140
Why?
Genome, Human
2
2021
110
0.140
Why?
Phenotype
3
2021
732
0.140
Why?
HIV Infections
2
2010
356
0.140
Why?
Receptors, Colony-Stimulating Factor
1
2016
1
0.130
Why?
CCAAT-Enhancer-Binding Proteins
1
2016
14
0.130
Why?
Cell Proliferation
4
2021
987
0.130
Why?
Neutropenia
1
1996
114
0.130
Why?
Immunologic Factors
2
2013
112
0.130
Why?
Treatment Outcome
3
2023
5203
0.130
Why?
Genotype
3
2013
542
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
579
0.130
Why?
DNA Copy Number Variations
1
2016
109
0.130
Why?
Influenza A Virus, H5N1 Subtype
1
2015
1
0.130
Why?
Registries
1
2018
527
0.120
Why?
Ribosome Subunits, Small, Eukaryotic
1
2014
2
0.120
Why?
K562 Cells
1
2014
41
0.120
Why?
Transcription Factors
3
2024
563
0.120
Why?
Chromosome Mapping
3
2011
158
0.120
Why?
Leukemia, Myeloid
1
2014
42
0.110
Why?
Influenza, Human
1
2015
83
0.110
Why?
Molecular Epidemiology
2
2010
39
0.110
Why?
Anemia, Macrocytic
1
2013
2
0.110
Why?
Prednisolone
1
2013
55
0.110
Why?
Cluster Analysis
2
2010
233
0.110
Why?
Cytogenetic Analysis
1
2013
80
0.110
Why?
Base Sequence
3
2010
653
0.110
Why?
Infant, Newborn
3
2019
2770
0.100
Why?
RNA, Messenger
4
2021
1097
0.100
Why?
Heart Defects, Congenital
1
2018
590
0.100
Why?
Genomics
1
2014
284
0.100
Why?
Chromosome Deletion
2
2013
140
0.100
Why?
Haploinsufficiency
1
2011
14
0.100
Why?
Mosaicism
1
2011
18
0.100
Why?
Genotyping Techniques
1
2011
20
0.100
Why?
Blotting, Northern
1
2011
110
0.100
Why?
RNA, Small Interfering
2
2008
210
0.090
Why?
Genome-Wide Association Study
1
2011
163
0.090
Why?
Neoplastic Stem Cells
2
2022
100
0.090
Why?
Typhoid Fever
1
2010
2
0.090
Why?
Salmonella typhi
1
2010
3
0.090
Why?
Case-Control Studies
2
2017
1145
0.090
Why?
Viremia
1
2010
22
0.090
Why?
Bacterial Typing Techniques
1
2010
39
0.090
Why?
Daunorubicin
2
2022
12
0.090
Why?
WT1 Proteins
1
2009
4
0.090
Why?
Antibodies, Viral
1
2010
94
0.090
Why?
Cytarabine
2
2022
40
0.090
Why?
DNA, Bacterial
1
2010
187
0.080
Why?
Viral Nonstructural Proteins
1
2010
56
0.080
Why?
Cohort Studies
2
2016
1414
0.080
Why?
Chromosomes, Human, Pair 3
1
2008
19
0.080
Why?
Pedigree
1
2008
125
0.080
Why?
Saccharomyces cerevisiae Proteins
1
2009
142
0.080
Why?
Chromosomes, Human, Pair 6
1
2007
15
0.070
Why?
Wilms Tumor
1
2007
18
0.070
Why?
Genes, Tumor Suppressor
1
2007
73
0.070
Why?
Severity of Illness Index
2
2024
959
0.070
Why?
Amino Acid Sequence
1
2008
576
0.070
Why?
Ubiquitin-Protein Ligases
1
2007
93
0.070
Why?
Molecular Sequence Data
1
2008
795
0.070
Why?
DNA Helicases
1
2008
144
0.070
Why?
Mice
4
2023
5673
0.070
Why?
Cell Differentiation
2
2021
648
0.070
Why?
Models, Biological
1
2009
722
0.070
Why?
Animals
6
2023
13141
0.070
Why?
Kidney Neoplasms
1
2007
173
0.060
Why?
Cell Line
1
2008
1010
0.060
Why?
Graft vs Host Disease
1
2005
73
0.060
Why?
Tacrolimus
1
2005
57
0.060
Why?
Insulin, Isophane
1
2024
1
0.060
Why?
Transcriptome
2
2017
316
0.060
Why?
DNA
1
2008
543
0.060
Why?
Autoimmune Diseases
1
2005
81
0.060
Why?
Follow-Up Studies
2
2020
2188
0.060
Why?
Nucleosome Assembly Protein 1
1
2024
1
0.060
Why?
Minor Histocompatibility Antigens
1
2024
17
0.060
Why?
Hyperglycemia
1
2024
81
0.060
Why?
Factor VIII
1
2024
23
0.060
Why?
Myeloid-Lymphoid Leukemia Protein
1
2024
14
0.060
Why?
Proto-Oncogenes
1
2024
27
0.060
Why?
DEAD-box RNA Helicases
1
2024
31
0.060
Why?
Outpatients
1
2024
115
0.060
Why?
Retinoblastoma-Binding Protein 2
1
2023
6
0.060
Why?
Nuclear Pore Complex Proteins
1
2023
11
0.060
Why?
Proto-Oncogene Proteins c-ret
1
2024
33
0.050
Why?
Autoantibodies
1
2024
114
0.050
Why?
CpG Islands
1
2023
106
0.050
Why?
Ambulatory Care
1
2024
225
0.050
Why?
Hypoglycemic Agents
1
2024
169
0.050
Why?
Apoptosis
1
2008
1093
0.050
Why?
Computational Biology
1
2024
214
0.050
Why?
Disease Management
1
2024
175
0.050
Why?
Hemorrhage
1
2024
196
0.050
Why?
Retrospective Studies
2
2024
6190
0.050
Why?
Insulin
1
2024
460
0.050
Why?
Vaccination
1
2024
275
0.050
Why?
Proto-Oncogene Proteins c-cbl
1
2022
3
0.050
Why?
Core Binding Factor beta Subunit
1
2021
3
0.050
Why?
Myosin Heavy Chains
1
2021
21
0.050
Why?
RNA
1
2022
166
0.050
Why?
Prevalence
2
2018
960
0.050
Why?
Gene Expression Regulation, Leukemic
1
2021
32
0.050
Why?
Disease Models, Animal
2
2021
1419
0.050
Why?
Enhancer Elements, Genetic
1
2021
58
0.050
Why?
Acetylation
1
2021
93
0.050
Why?
RNA-Binding Proteins
1
2021
119
0.050
Why?
Trans-Activators
1
2021
135
0.040
Why?
Genetic Association Studies
1
2021
115
0.040
Why?
HEK293 Cells
1
2021
217
0.040
Why?
Mice, Inbred BALB C
1
2021
296
0.040
Why?
Up-Regulation
1
2021
446
0.040
Why?
Receptors, GABA-A
1
2019
12
0.040
Why?
Cell Transformation, Neoplastic
1
2021
181
0.040
Why?
Pandemics
1
2024
567
0.040
Why?
Hematopoietic Stem Cells
1
2021
182
0.040
Why?
Oxidative Stress
1
2024
763
0.040
Why?
Cell Line, Tumor
1
2023
1390
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2024
556
0.040
Why?
Protein Binding
1
2021
655
0.040
Why?
Histones
1
2021
296
0.040
Why?
Feasibility Studies
1
2020
383
0.040
Why?
Combined Modality Therapy
1
2020
639
0.040
Why?
Pilot Projects
1
2020
703
0.040
Why?
Etoposide
1
2017
71
0.040
Why?
Erythroid Cells
1
2017
5
0.040
Why?
Genes, Dominant
1
2017
19
0.040
Why?
Erythropoiesis
1
2017
16
0.040
Why?
Genes, X-Linked
1
2017
7
0.040
Why?
Models, Genetic
1
2017
174
0.030
Why?
Protein-Tyrosine Kinases
1
1996
94
0.030
Why?
Basic Reproduction Number
1
2015
1
0.030
Why?
Promoter Regions, Genetic
1
2017
466
0.030
Why?
Family Health
1
2015
79
0.030
Why?
Epigenesis, Genetic
1
2017
371
0.030
Why?
Methylation
1
2014
118
0.030
Why?
Placebos
1
2013
85
0.030
Why?
T-Lymphocytes, Cytotoxic
1
2013
65
0.030
Why?
Immunomodulation
1
2013
37
0.030
Why?
Chromosomes, Human, Pair 5
1
2013
17
0.030
Why?
Treatment Failure
1
2013
116
0.030
Why?
Cells, Cultured
1
2017
1587
0.030
Why?
Killer Cells, Natural
1
2013
107
0.030
Why?
Models, Statistical
1
2014
225
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.030
Why?
Age Factors
1
2015
1096
0.020
Why?
Thalidomide
1
2013
374
0.020
Why?
Cryptococcus gattii
1
2010
1
0.020
Why?
Flucytosine
1
2010
14
0.020
Why?
Cytokines
1
2013
607
0.020
Why?
DNA Gyrase
1
2010
4
0.020
Why?
Risk Assessment
1
2015
1255
0.020
Why?
Nepal
1
2010
11
0.020
Why?
Algorithms
1
2014
615
0.020
Why?
Reagent Kits, Diagnostic
1
2010
18
0.020
Why?
Immunoassay
1
2010
20
0.020
Why?
High-Throughput Screening Assays
1
2010
35
0.020
Why?
Amphotericin B
1
2010
110
0.020
Why?
Haplotypes
1
2010
84
0.020
Why?
Drug Resistance, Bacterial
1
2010
73
0.020
Why?
Point-of-Care Systems
1
2010
56
0.020
Why?
RNA, Viral
1
2010
124
0.020
Why?
Microbial Sensitivity Tests
1
2010
272
0.020
Why?
Retroviridae
1
2008
5
0.020
Why?
Anaerobiosis
1
2008
18
0.020
Why?
Disease-Free Survival
1
2009
450
0.020
Why?
Transduction, Genetic
1
2008
45
0.020
Why?
Gene Knockdown Techniques
1
2008
106
0.020
Why?
Ankyrin Repeat
1
2007
3
0.020
Why?
Sensitivity and Specificity
1
2010
871
0.020
Why?
Aged, 80 and over
1
2015
3158
0.020
Why?
Mice, Mutant Strains
1
2007
71
0.020
Why?
Antifungal Agents
1
2010
343
0.020
Why?
Survival Rate
1
2009
906
0.020
Why?
Signal Transduction
1
2014
1612
0.020
Why?
Bacterial Proteins
1
2010
372
0.020
Why?
Fibroblasts
1
2008
352
0.020
Why?
Absorption
1
2005
21
0.020
Why?
Oxygen
1
2008
321
0.020
Why?
Administration, Topical
1
2005
57
0.020
Why?
Bone Marrow Transplantation
1
2005
112
0.020
Why?
Skin Diseases
1
2005
114
0.010
Why?
Genetic Predisposition to Disease
1
2007
508
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2007
824
0.010
Why?
Farrar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description